Multicomponent Exercise Program Effects on Performance and Injury Reduction in Recreational Runners

July 31, 2026 updated by: Yeditepe University

THE IMPACT OF A MULTICOMPONENT EXERCISE PROGRAM ON ATHLETIC PERFORMANCE, PHYSICAL PARAMETERS, AND INJURY REDUCTION IN RECREATIONAL RUNNERS: A RANDOMIZED CONTROLLED TRIAL.

Study aim was to evaluate effectiveness of two home-based exercise programs upon athletic performance, physical parameters and injury reduction in recreational runners. Participants were randomized to multicomponent and traditional strength exercise program in block randomization. Primary outcomes were maximal oxygen uptake (VO2Max) calculated with 20 meter (m) shuttle run test (20m SRT), muscle strength of quadriceps femoris, hamstring and gluteus medius calculated via handheld dynamometer (HHD), plyometric performance measured via countermovement jump (CMJ) and drop jump (DJ), foot posture assessment with foot posture index and navicular drop, core endurance with prone bridge, side bridge and horizontal extension and calf endurance values. Secondary outcome was injury reduction followed via self made questionnaire that was sent each week to the participants in order them to record injury and training characteristic of that with including running and exercise program. Programs were given online without supervision 2-3 times a week. Study consisted of 16-weeks with 8-week training, and 8 weeks follow up including baseline and 8th week assessment. In each assessment all the primary outcomes measured.

H0: There will be no improvement in athletic performance, physical parameters, and injury risk after the multi-component exercise program.

H1: There will be improvement in athletic performance, physical parameters, and injury risk after the multi-component exercise program.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Suspended

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Interventional

Enrollment (Actual)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
29

Phase

Phase

The stage of a clinical trial studying a drug or biological product, based on definitions developed by the U.S. Food and Drug Administration (FDA). The phase is based on the study's objective, the number of participants, and other characteristics. There are five phases: Early Phase 1 (formerly listed as Phase 0), Phase 1, Phase 2, Phase 3, and Phase 4. Not Applicable is used to describe trials without FDA-defined phases, including trials of devices or behavioral interventions.
  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey (Türkiye)
    • Kadıköy
      • Istanbul, Kadıköy, Turkey (Türkiye), 34726
        • PT Academy

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • The primary sport must be running.
  • Be between 18 and 65 years of age.
  • Participate in races.
  • Run 20-100 km per week.
  • Have at least 12 months of regular running experience.
  • At least 3 running training sessions per week.

Exclusion Criteria:

  • Did not injured in the last 3 months.
  • Did not undergone surgery in the last 12 months.
  • Did not have any issues that limit strength training.
  • Did not having any neurological, tumor, cardiovascular, rheumatological, or hormonal diseases.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm

Participant Group / Arm

A group or subgroup of participants in a clinical trial that receives a specific intervention/treatment, or no intervention, according to the trial's protocol.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
Experimental: Multicomponent Exercise Group
Other: Multicomponent Exercise Program
Intervention group received an exercise program that includes same warm-up and cool-down periods containing strength and flexibility exercises with control group. Participants performed the exercises on their own using videos without supervision at home. The multicomponent exercise program which was intervention group included plyometric, strength, and core (lumbopelvic and foot region) exercises. The program was implemented 2-3 times per week. Exercises delivered to participants via Google Drive using exercise videos recorded by researchers, ensuring proper technique was maintained, allowing participants to perform the exercises at home without supervision. Additionally, detailed information about the exercise system and important considerations or precautions while doing the exercise were told in videos. Furthermore, general guidelines including, detailed information about study, drop out criteria, precautions for
Active Comparator: Traditional Strength Exercise Group
Other: Traditional Exercise Program
Control group received an exercise program that includes same warm-up and cool-down periods containing strength and flexibility exercises with intervention group. Participants performed the exercises on their own using videos without supervision at home. The control group only received strength and core exercises. The program was implemented 2-3 times per week. Exercises delivered to participants via Google Drive using exercise videos recorded by researchers, ensuring proper technique was maintained, allowing participants to perform the exercises at home without supervision. Additionally, detailed information about the exercise system and important considerations or precautions while doing the exercise were told in videos. Furthermore, general guidelines including, detailed information about study, drop out criteria, precautions for

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Countermovement Jump
Time Frame: Baseline and 8th week assessment
In order to execute the jump the participant jumped with fast deceleration till 90-degree squat position followed by maximum effort acceleration while holding their hand on their hip. Subjects should perform three jumps, and the best of the three was used. There should be 1-minute rest period between repetitions .
Baseline and 8th week assessment
Drop Jump
Time Frame: Baseline and 8th week assessment
The participant will perform drop jump from a 30 cm box. They should keep their hands on their hips while executing the jump all the time. At the start of the jump, the participant must step off the box with one foot. After drop patient should jump maximally as soon as possible after touching the ground. Therefore, minimum ground contact time and maximum vertical distance were expected Three trials should executed, and the best one will used in the analysis
Baseline and 8th week assessment
Gluteus Medius Strength
Time Frame: Baseline and 8th week assessment
Isometric strength of the gluteus medius will be assessed using the Microfet 2 handheld dynamometer, which was reliable for measuring the hip muscle system. The participant must exert maximal effort for 5 seconds in a predetermined direction which was hip abduction in this case. Two repetitions will be performed, and the best result will be recorded. Hip abduction will be measured in the side-lying position with the contralateral leg flexed at 30 degrees at the hip and knee. The tested leg will be positioned at 0 degrees hip flexion, 10 degrees hip abduction, and full knee extension. The dynamometer will be placed 5 cm proximally to the lateral condyle of the femur. A strap will be used to secure the patient from the iliac crest to the bed . Before executing the test 3 sets of 5 second submaximal contraction required for warm up.
Baseline and 8th week assessment
Quadriceps Femoris Strength
Time Frame: Baseline and 8th week assessment.
the handheld dynamometer was applicable for assessing quadriceps peak torque and late torque production rate . The intraclass correlation coefficient for isometric quadriceps measurements was 0.96. The dynamometer was secured by attaching a strap to leg extension machine . The quadriceps muscle strength will be assessed while seated with the knee flexed at 60 degrees. Three trials will be used and the best one will be recorded . There will be three submaximal contractions for adaptation for warm up . The dynamometer will be placed on the anterior tibia, two fingers above the lateral malleolus . Handles will be used to secure participants. Maximum leg extension will be wanted from patient to measure strength after positioning patient for about 6-8 second.
Baseline and 8th week assessment.
Hamstring Strength
Time Frame: Baseline and 8th week assessment.
The assessment will be performed with the knee flexed at 30 degrees in a seated position in a leg extension machine secured by straps from thigh and handles in the sides [88,89]. Three trials will be used, and the best one will be recorded . There will be three submaximal contractions for adaptation and warm up beforehand . The dynamometer will be at the level of the lateral malleolus, and the evaluator stabilizing the dynamometer strap using their body . Maximum leg flexion will be wanted from patient to measure strength after positioning patient for about 6-8 second.
Baseline and 8th week assessment.
Calf Endurance
Time Frame: Baseline and 8th week assessment
Calf endurance test was valid test for assessing calf endurance. The participants will perform as many calves raises as possible on a 10-degree inclined surface, extending their knees and using a metronome of 30 beats per minute representing 30 repetitions per minute . Before the test, each participant will warm up with ten bilateral standing heel raises to get used to the metronome speed. The test termination criteria will be explained to the participants which were if the heel can no longer be raised off the incline board, if the digital metronome's pace can no longer be followed and if the knee angle or trunk posture can no longer be maintained or more than fingertip support on the wall is required for balance. A verbal cue was supplied if a termination requirement was met. When two successive prompts went unanswered, the test was stopped .
Baseline and 8th week assessment
Core endurance
Time Frame: Baseline and 8th week assessment
The participant will be asked to maintain the maximum duration in seconds throughout the predefined positions. The posterior core will be assessed using the horizontal extension test, the lateral core using the lateral bridge, and the anterior core using the prone bridge.
Baseline and 8th week assessment
Foot posture index
Time Frame: Baseline and 8th week assessment
FPI consisted of 6 measurements which were themed from parts of the foot such as forefoot, midfoot and rearfoot. Each evaluation scored with 5 scores consisting of -2 to +2. These evaluations were: talar head palpation, curves above and below lateral malleolus, inversion and eversion of the calcaneus, bulge in the region of talonavicular joint, congruence of the medial longitudinal arch, abduction and adduction of forefoot on the rearfoot (too-many-toes) .Participant will evaluated in a relaxed standing position .
Baseline and 8th week assessment
Navicular drop
Time Frame: Baseline and 8th week assessment
The distance from navicular tuberosity will be measured via using a meter in sitting position when subtalar joint was in neutral position. After that same distance will be measured in weight bearing position. The difference between the two measurements will give the navicular drop difference.
Baseline and 8th week assessment
Shuttle Run Test
Time Frame: Baseline and 8th week assessment
When the athlete begins the test, their speed was 8.5 kilometers per hour (km/h) and were increased by 0.5 km/h in every minute. The test stopped if the athlete cannot keep up with the pace or fails to complete the shuttle within the predetermined time limits on two consecutive attempts . VO2 max values calculated according to the results described by Ramsbotton and colleagues and the VO2 max conversion table .
Baseline and 8th week assessment

Secondary Outcome Measures

Secondary Outcome Measures

In a clinical study's protocol, a planned outcome measure that is not as important as the primary outcome measure for evaluating the effect of an intervention but is still of interest. Most clinical studies have more than one secondary outcome measure.
Outcome Measure
Measure Description
Time Frame
Injury Tracking Assessment
Time Frame: Baseline to 16th week in each week questionnaire sent.
Injury tracking and training-related variables will be collected through questionnaire that was created for this study. The questionnaire will be self-administered and will used to assess the incidence and prevalence of injuries. It included questions about how many sessions of the programs were performed weekly and the duration of each session. Additionally, there were questions about the number of weekly running training sessions, the surface, the distance covered, and the duration of each session. Finally, there were questions about whether an injury occurred, the location of the injury, how (sudden or gradual) and when the pain manifested. An injury was classified as a running-related injury resulting inability to participate in the next training session due to any musculoskeletal complaint . A Google form will be used to collect these questions.
Baseline to 16th week in each week questionnaire sent.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Yeditepe University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
September 10, 2025

Primary Completion (Actual)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
May 10, 2026

Study Completion (Estimated)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
May 10, 2027

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
July 23, 2026

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
July 31, 2026

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
August 3, 2026

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
August 3, 2026

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
July 31, 2026

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
July 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • 202506Y0873

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

All data can be presented.

IPD Sharing Time Frame

As soon as possible.

IPD Sharing Access Criteria

Researchers who need it for science.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • ICF
  • ANALYTIC_CODE
  • CSR

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings